W911QY18F0007↗
Battelle Memorial Institute received this contract from W6QK Acc-Apg, Department of the Army: $679.0K obligated so far for support- professional: other. Its period of performance ended 2025-02-11.
Key facts · data as of Oct 28, 2026
- Recipient
- Battelle Memorial Institute
- Awarding agency
- Department of the Army (Department of Defense)
- Contracting office
- W6QK Acc-Apg (W911SR)
- Obligated to date
- $679.0K
- Potential value
- $51.31M
- Ends
- 2025-02-11
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 28, 2026.
Cite this page: SpendQuery, Award W911QY18F0007, data as of Oct 28, 2026, https://spendquery.com/award?id=CONT_AWD_W911QY18F0007_9700_GS00Q14OADU402_4732
Battelle Memorial Institute: all federal awards · Department of Defense: spending · W6QK Acc-Apg: what it buys
WEEVEE VACCINE
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Biotechnology) (NAICS 541712)
- Contracting office
- W6QK Acc-Apg (W911SR)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Cost plus fixed fee
- How it was bought
- Multiple-award IDIQ · under OASIS (GS00Q14OADU402)
- Where the work is
- Franklin, OH · district OH-03
- Funding law
- COVID-19 laws
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
9 actions since 2023-03-10. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-09-22 | P00046 | Funding only | -$2 | TO DESIGN AND CONDUCT CLINICAL AND NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND REPORT STUDY RESULTS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR MEDICAL PRODUCTS. |
| 2025-09-08 | P00045 | Funding only | -$3.6K | TO DESIGN AND CONDUCT CLINICAL AND NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND REPORT STUDY RESULTS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR MEDICAL PRODUCTS. |
| 2024-11-04 | P00044 | Change order | -$228.3K | TO DESIGN AND CONDUCT CLINICAL AND NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND REPORT STUDY RESULTS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR MEDICAL PRODUCTS. |
| 2024-08-08 | P00043 | Funding only | $175.6K | THE REQUIREMENT IS TO DESIGN AND CONDUCT NONCLINICAL AND CLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS,AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR… |
| 2024-08-01 | P00042 | Funding only | -$175.6K | THIS ORDER IS FOR THE DESIGN AND CONDUCT OF NONCLINICAL AND CLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES… |
| 2024-02-08 | P00041 | Funding only | $222.4K | THE DEPARTMENT OF DEFENSE (DOD) SUPPORTS THE DEVELOPMENT OF VACCINES THAT ARE DIRECTED AGAINST VALIDATED BIOLOGICAL WARFARE (BW) WEAPONS TO INCLUDE BACTERIA, VIRUSES, AND TOXINS OF BIOLOGICAL ORIGIN. VACCINES HAVE BEEN IDENTIFIED AS THE MOST EFFICIENT… |
| 2023-11-16 | P00040 | Change order | $0 | WEEVEE VACCINE |
| 2023-05-30 | P00039 | Change order | $400.4K | WEEVEE VACCINE |
| 2023-03-10 | P00038 | Supplemental agreement (work within scope) | $288.1K | WEEVEE VACCINE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-28). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗